Tutzing, Germany

Joachim Helbig

This inventor holds 9 USPTO granted patents. Top assignees: Verla-Pharm Arzneimittel-Fabrik Apotheker H. J. V. Ehrlich, Verla-Pharm Arzneimittelfabrik Apotheker H.j.v. Ehrlich Gmbh & Co. Kg, Bayer Aktiengesellschaft. Active years: 1977-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim Helbig. Retrieved from https://idiyas.com/inventor/joachim-helbig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 88.9

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 74(Granted Patents)


Location History:

  • Tutzing, DE (1977 - 1992)
  • Köln, DE (2006)

Company Filing History:


Years Active: 1977-2006

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Joachim Helbig - Innovative Inventor from Tutzing, DE

Introduction: Joachim Helbig is a renowned inventor hailing from Tutzing, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Joachim Helbig holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Joachim Helbig has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Joachim Helbig has collaborated with top engineers, scientists, and inventors, fostering a culture of creativity and excellence in all his projects.

Conclusion: Joachim Helbig's passion for innovation and his dedication to creating a more sustainable future continue to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…